Myeloid cell-mediated killing of B-ALL by CD38 and CD20IgA antibody variants is enhanced by CD47/SIRPα interference
Maja Kowol, Marta Lustig, Annette M. Hartmann, Ida C. van der Peet, Marco Jansen, Dorothee Winterberg, Steffen Krohn, Niklas Baumann, Thies Rösner, Sonja Bendig, Alexander Arthur Wurm, Monika Brüggemann, Renate Burger, Kerstin Schmitt, Oliver Valerius, , Thomas Valerius
This study evaluates the efficacy of CD38 and CD20 IgG1/IgA2 antibodies in mediating myeloid cell-mediated killing of B-ALL, showing enhanced activity with CD47/SIRPα blockade.
bioRxiv · Aug 13, 2025 · PreprintCancer Biology